Live feed08:30:00·22dPRReleaseIntelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening MarketINBS· Intelligent Bio Solutions Inc.Health CareOriginal source
